Sleep–wake disorders persist 18 months after traumatic brain injury but remain underrecognized
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 22, 2015
- Accepted in final form February 1, 2016
- First Published April 27, 2016.
Article Versions
- Previous version (April 27, 2016 - 13:07).
- You are viewing the most recent version of this article.
Author Disclosures
- Lukas L. Imbach, MD*,
- Fabian Büchele, MD*,
- Philipp O. Valko, MD,
- Tongzhou Li,
- Angelina Maric, MSc,
- John F. Stover, MD,
- Claudio L. Bassetti, MD,
- Ladislav Mica, MD,
- Esther Werth, PhD and
- Christian R. Baumann, MD
- Lukas L. Imbach, MD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Swiss National Science Foundation (SNF 125504), Site Investigator Jan 2011 - Dec 2011
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Fabian Büchele, MD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Philipp O. Valko, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Tongzhou Li,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Angelina Maric, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- John F. Stover, MD,
NONE
NONE
NONE
NONE
NONE
NONE
Fresenius Kabi, Vice President; not related to this manuscript
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Claudio L. Bassetti, MD,
Commercial, Bohringer Ingelheim Commercial, Cephalon Commercial,Jazz Commercial, Lundbeck Commercial, Pfizer Commercial, ResMed Commercial, Respironics Commercial, UCB Pharma Commercial, Vifor Pharma
NONE
Commercial, Bohringer Ingelheim Commercial, Cephalon Commercial,Jazz Commercial, Lundbeck Commercial, Pfizer Commercial, ResMed Commercial, Respironics Commercial, UCB Pharma Commercial, Vifor Pharma
Prof. Bassetti serves as Chief Editor of the Swiss Archives of Neurology and Psychiatry (past 2 years) Is on the editorial boards of the Journal of Sleep Research (past 2 years) Is on the editorial board of Sleep Medicine (past 2 years) Is on the editorial boardof Somnology (past 2 years) Is on the editorial board of Sleep (past 2 years) Is on the editorial board of European Neurology (past 2 years) Is on the editoarial board of the Belgian Neurological Journal (past 2 years)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ladislav Mica, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Esther Werth, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Christian R. Baumann, MD
(1) Commercial entity: Teva Pharmaceuticals, Advisory Board.
NONE
(1) Commercial entity: Speaker honoraria and travel compensation for a scientific symposium.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) UCB Pharmaceuticals.
(1) Swiss National Foundation, grant number: 32003B_125504/1, principle investigator, 2010-2014.
(1) University of Zurich, Clinical Research Priority Program
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Neurology (L.L.I., F.B., P.O.V., T.L., A.M., E.W., C.R.B.) and Traumatology (J.F.S., L.M.), University Hospital Zurich; and Department of Neurology (C.L.B.), Inselspital Bern, Switzerland.
- Correspondence to Dr. Imbach: lukas.imbach{at}usz.ch
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
- Sleep-wake disorders in TBI and the role of mental fatigue
- Joukje van der Naalt, Neurologist, Department of Neurology, University of Groningen, University Medical Center Groningen the Netherlandj.van.der.naalt@umcg.nl
- Bram Jacobs
Submitted June 08, 2016 - Head injury and its impact on sleep hygiene: An entity slowly coming out of the shell
- Sunil Munakomi, MCh Resident, Kathmandu University, Nepalsunilmunakomi@gmail.com
Submitted May 13, 2016
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.